Mirum Pharmaceuticals, Inc. (35) | License Agreements (7)

Recent Contracts

License Agreement by and between Lumena Pharmaceuticals, Inc. and Sanofi-Aventis Deutschland GmbH, dated September 27, 2012 (Filed With SEC on July 8, 2019)
License Agreement by and between Lumena Pharmaceuticals, Inc. and Satiogen Pharmaceuticals, Inc., dated February 8, 2011 (Filed With SEC on June 21, 2019)
Amendment to License Agreement by and between Lumena Pharmaceuticals, Inc. and Satiogen Pharmaceuticals, Inc., dated February 28, 2011 (Filed With SEC on June 21, 2019)
License Agreement by and between Lumena Pharmaceuticals, Inc. and Pfizer Inc., dated June 1, 2012 (Filed With SEC on June 21, 2019)
Amendment No. 1 to License Agreement by and between Shire Orphan and Rare Disease GmbH (successor in interest of Lumena Pharmaceuticals, Inc.) and Sanofi-Aventis Deutschland GmbH,... (Filed With SEC on June 21, 2019)
Assignment and License Agreement by and between the Registrant and Shire International GmbH, dated November 5, 2018 (Filed With SEC on June 21, 2019)
License Agreement by and between Lumena Pharmaceuticals, Inc. and Sanofi-Aventis Deutschland GmbH, dated September 27, 2012 (Filed With SEC on June 21, 2019)